NOVONIX Limited announced that the effective date for the appointment of Andrew N. Liveris AO to its Board of Directors as 1 July 2018. As announced, the appointment of Mr. Liveris is a further step in the implementation of the company's downstream integration strategy. The appointment will follow Liveris' transition from his roles with Dow and DowDuPont. Mr. Liveris is currently the Chairman of and Chief Executive Officer of The Dow Chemical Company and a director of DowDuPont.